Source: Siyu MedTech; Editor: Sophia
Reprint requirements: Can be reprinted 24 hours after the first publication, source must be credited.
July 31, 2024GE Healthcare announcedFinancial results for the second quarter ended June 30, 2024.Peter Arduini, President and CEO of GE HealthCare, said:"Despite the headwinds in China during the second quarter, sales achieved year-over-year growth and profit margins expanded. Thanks to investments in enhancing patient care technology and improving productivity, orders in the U.S. showed steady growth. The company is pleased with the progress made toward its profit objectives and will continue to invest for future growth."
# Highlights of Financial ReportThe marketing revenue for the second quarter was$4.8 billion (approximately 34.8 billion RMB), Organic growth increased by 1%;The company's total order-to-shipment ratio (defined as total orders divided by total revenue) remained stable at 1.06; the total order value increased organically by 3% year-over-year.Net profit attributable to GEHealthcare，Last year for$418 million；Adjusted EBIT (Earnings Before Interest and Taxes) is, last year it was 7.11 billion US dollars;Net Profit Margin, up 20 basis points from 8.7% in the same period last year；, up 60 basis points from the previous 14.8%;Diluted earnings per share$0.93, last year it was $0.91;Adjusted Earnings Per ShareFor。- Outlook for Fiscal Year 2024
The company updated its guidance for full-year 2024 organic revenue growth and adjusted EBIT margin, and reiterated other metrics as follows:Organic revenue growth inwithin the range, a slight decrease compared to the previously set 4%, due to headwinds in the Chinese market;Within the range, it has slightly increased compared to the previously set range of 15.6%-15.9%;Adjusted Earnings Per Share Range isFree cash flow is approximatelyOn July 25, GE Healthcare announced that it is collaborating with Amazon Web Services to build generative AI models and applications specifically for healthcare.The healthcare industry is responsible for generating nearly one-third of the world's data, but this data is not stored or organized uniformly, resulting in "data silos."GE Healthcare and AWS believe that AI can help doctors find the information they need more quickly and utilize the tool in workflows such as screening, diagnosis, decision support, and scheduling.July 18, 2024GE Healthcare announces agreement to acquire Intelligent Ultrasound's clinical artificial intelligence (AI) software business for approximately $51 million.Intelligent Ultrasound is committed to making ultrasound examinations smarter and more efficient through AI-based ultrasound image analysis tools. GE Healthcare plans to integrate these solutions into its ultrasound products.
On July 11, 2024, MIM Software, a subsidiary of GE Healthcare, launched new software named MIM Symphony HDR Prostate.The software aims to align the contours on preoperative MRI images with real-time ultrasound images and provide clear visibility of the prostate, lesion areas, and critical structures during HDR treatment.On June 25, 2024, GE Healthcare and MediView XR announced in Minneapolis, Minnesota, at North Star Vascular and InterventionalSuccessful Deployment of OmnifyXR Interventional Imaging Suite and Clinical Use Initiated.This innovative interventional imaging suite, based on augmented reality technology, integrates holographic real-time medical imaging, 3D anatomical model visualization, and advanced imaging techniques while supporting remote collaboration, helping to advance precision treatment in interventional procedures.
June 10, 2024,GEHealthcareAnnounced two key executive appointments,"Appointed respectively "Imaging Business" and "Ultrasound and Image-Guided Therapy (IGT)" New President and Chief Executive Officer.In connection with thisAt the same time, the company also announced a restructuring of the aforementioned core businesses, aiming to enhance its flexibility and market competitiveness in the field of healthcare innovation.On January 4, 2023, GE Healthcare announced that the previously announced spin-off from GE Group (NASDAQ: GE) has been completed. GE Healthcare will begin trading on the Nasdaq Stock Exchange as an independent company with the stock code "GEHC," effective at market open.GE Healthcare has approximately 51,000 employees worldwide, serving over 1 billion patients annually across more than 160 countries.GE Healthcare's business covers four major segments ——Medical Imaging、Ultrasound、PCS Patient Care SolutionsAndDrug Diagnosis。In the first quarter of the 2024 fiscal year, the company's total revenueRevenue was $4.6 billion, a year-over-year decrease of 1%.Net profit of $3.74 billion. Revenue from the imaging division was $24.66 billion, a year-on-year decrease of 1%; ultrasound division revenue was $8.24 billion, a year-on-year decrease of 4%.
Editor-in-Chief | Zhao Qing Reviewed by | Yi He
